4//SEC Filing
A2A Pharmaceuticals, Inc. 4
Accession 0001859061-23-000002
CIK 0001840439other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 6:43 PM ET
Size
4.8 KB
Accession
0001859061-23-000002
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-03-31$31.25/sh+200,000$6,250,000→ 4,100,000 total
Footnotes (1)
- [F1]A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64
Documents
Issuer
Biomea Fusion, Inc.
CIK 0001840439
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001859061
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 6:43 PM ET
- Size
- 4.8 KB